美国处方药支出预测及关键政策影响 - Suppr

Suppr

超能文献

Projections of US Prescription Drug Spending and Key Policy Implications.

作者信息

Conti Rena M, Turner Ani, Hughes-Cromwick Paul

机构信息

Boston University Institute for Health System Innovation & Policy, Boston, Massachusetts.

Boston University Questrom School of Business, Boston, Massachusetts.

出版信息

JAMA Health Forum. 2021 Jan 4;2(1):e201613. doi: 10.1001/jamahealthforum.2020.1613.

DOI:10.1001/jamahealthforum.2020.1613

PMID:36218435

Abstract

摘要

相似文献

Projections of US Prescription Drug Spending and Key Policy Implications.

JAMA Health Forum. 2021 Jan 4;2(1):e201613. doi: 10.1001/jamahealthforum.2020.1613.

Twelve years' experience with direct-to-consumer advertising of prescription drugs in Canada: a cautionary tale.

PLoS One. 2009 May 27;4(5):e5699. doi: 10.1371/journal.pone.0005699.

Impact of U.S. federal and state generic drug policies on drug use, spending, and patient outcomes: A systematic review.

Res Social Adm Pharm. 2020 Jun;16(6):736-745. doi: 10.1016/j.sapharm.2019.08.031. Epub 2019 Aug 17.

National trends in prescription drug expenditures and projections for 2016.

Am J Health Syst Pharm. 2016 Jul 15;73(14):1058-75. doi: 10.2146/ajhp160205. Epub 2016 May 11.

National trends in prescription drug expenditures and projections for 2014.

Am J Health Syst Pharm. 2014 Mar 15;71(6):482-99. doi: 10.2146/ajhp130767.

National trends in prescription drug expenditures and projections for 2019.

Am J Health Syst Pharm. 2019 Jul 18;76(15):1105-1121. doi: 10.1093/ajhp/zxz109.

National trends in prescription drug expenditures and projections for 2017.

Am J Health Syst Pharm. 2017 Aug 1;74(15):1158-1173. doi: 10.2146/ajhp170164. Epub 2017 May 22.

National trends in prescription drug expenditures and projections for 2020.

Am J Health Syst Pharm. 2020 Jul 23;77(15):1213-1230. doi: 10.1093/ajhp/zxaa116.

The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.

JAMA. 2016;316(8):858-71. doi: 10.1001/jama.2016.11237.

International Reference Pricing for Prescription Drugs in the United States: Administrative Limitations and Collateral Effects.

Value Health. 2021 Apr;24(4):473-476. doi: 10.1016/j.jval.2020.11.009. Epub 2020 Dec 31.

引用本文的文献

The impact of periodic updates to health benefits plan: access gains without cost savings?

Int J Health Econ Manag. 2025 Apr 9. doi: 10.1007/s10754-025-09394-7.

Association Between New 340B Program Participation and Commercial Insurance Spending on Outpatient Biologic Oncology Drugs.

JAMA Health Forum. 2023 Jun 2;4(6):e231485. doi: 10.1001/jamahealthforum.2023.1485.

Results of Leveraging Pharmaceutical Patient Assistance Programs to Expand Access to High Cost Medications in a Student-Run Free Clinic.

J Community Health. 2023 Dec;48(6):919-925. doi: 10.1007/s10900-023-01240-6. Epub 2023 Jun 7.

Effects of Real-time Prescription Benefit Recommendations on Patient Out-of-Pocket Costs: A Cluster Randomized Clinical Trial.

JAMA Intern Med. 2022 Nov 1;182(11):1129-1137. doi: 10.1001/jamainternmed.2022.3946.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Projections of US Prescription Drug Spending and Key Policy Implications.

作者信息

Conti Rena M, Turner Ani, Hughes-Cromwick Paul

机构信息

Boston University Institute for Health System Innovation & Policy, Boston, Massachusetts.

Boston University Questrom School of Business, Boston, Massachusetts.

出版信息

JAMA Health Forum. 2021 Jan 4;2(1):e201613. doi: 10.1001/jamahealthforum.2020.1613.

DOI:10.1001/jamahealthforum.2020.1613

PMID:36218435

Abstract

摘要

相似文献

Projections of US Prescription Drug Spending and Key Policy Implications.

JAMA Health Forum. 2021 Jan 4;2(1):e201613. doi: 10.1001/jamahealthforum.2020.1613.

Twelve years' experience with direct-to-consumer advertising of prescription drugs in Canada: a cautionary tale.

PLoS One. 2009 May 27;4(5):e5699. doi: 10.1371/journal.pone.0005699.

Impact of U.S. federal and state generic drug policies on drug use, spending, and patient outcomes: A systematic review.

Res Social Adm Pharm. 2020 Jun;16(6):736-745. doi: 10.1016/j.sapharm.2019.08.031. Epub 2019 Aug 17.

National trends in prescription drug expenditures and projections for 2016.

Am J Health Syst Pharm. 2016 Jul 15;73(14):1058-75. doi: 10.2146/ajhp160205. Epub 2016 May 11.

National trends in prescription drug expenditures and projections for 2014.

Am J Health Syst Pharm. 2014 Mar 15;71(6):482-99. doi: 10.2146/ajhp130767.

National trends in prescription drug expenditures and projections for 2019.

Am J Health Syst Pharm. 2019 Jul 18;76(15):1105-1121. doi: 10.1093/ajhp/zxz109.

National trends in prescription drug expenditures and projections for 2017.

Am J Health Syst Pharm. 2017 Aug 1;74(15):1158-1173. doi: 10.2146/ajhp170164. Epub 2017 May 22.

National trends in prescription drug expenditures and projections for 2020.

Am J Health Syst Pharm. 2020 Jul 23;77(15):1213-1230. doi: 10.1093/ajhp/zxaa116.

The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.

JAMA. 2016;316(8):858-71. doi: 10.1001/jama.2016.11237.

International Reference Pricing for Prescription Drugs in the United States: Administrative Limitations and Collateral Effects.

Value Health. 2021 Apr;24(4):473-476. doi: 10.1016/j.jval.2020.11.009. Epub 2020 Dec 31.

引用本文的文献

The impact of periodic updates to health benefits plan: access gains without cost savings?

Int J Health Econ Manag. 2025 Apr 9. doi: 10.1007/s10754-025-09394-7.

Association Between New 340B Program Participation and Commercial Insurance Spending on Outpatient Biologic Oncology Drugs.

JAMA Health Forum. 2023 Jun 2;4(6):e231485. doi: 10.1001/jamahealthforum.2023.1485.

Results of Leveraging Pharmaceutical Patient Assistance Programs to Expand Access to High Cost Medications in a Student-Run Free Clinic.

J Community Health. 2023 Dec;48(6):919-925. doi: 10.1007/s10900-023-01240-6. Epub 2023 Jun 7.

Effects of Real-time Prescription Benefit Recommendations on Patient Out-of-Pocket Costs: A Cluster Randomized Clinical Trial.

JAMA Intern Med. 2022 Nov 1;182(11):1129-1137. doi: 10.1001/jamainternmed.2022.3946.